001441428 000__ 04295cam\a2200553Ii\4500
001441428 001__ 1441428
001441428 003__ OCoLC
001441428 005__ 20230309004738.0
001441428 006__ m\\\\\o\\d\\\\\\\\
001441428 007__ cr\cn\nnnunnun
001441428 008__ 220104s2021\\\\sz\\\\\\o\\\\\000\0\eng\d
001441428 019__ $$a1292518753$$a1294361017
001441428 020__ $$a9783030793081$$q(electronic bk.)
001441428 020__ $$a3030793087$$q(electronic bk.)
001441428 020__ $$z9783030793074$$q(print)
001441428 0247_ $$a10.1007/978-3-030-79308-1$$2doi
001441428 035__ $$aSP(OCoLC)1290777367
001441428 040__ $$aGW5XE$$beng$$erda$$epn$$cGW5XE$$dEBLCP$$dDKU$$dOCLCO$$dDCT$$dOCLCF$$dSFB$$dOCLCO$$dUKAHL$$dOCLCQ
001441428 049__ $$aISEA
001441428 050_4 $$aRM275
001441428 08204 $$a615.3/7$$223
001441428 24500 $$aImmunotherapy /$$cedited by Aung Naing, Joud Hajjar.
001441428 250__ $$aFourth edition.
001441428 264_1 $$aCham :$$bSpringer,$$c2021.
001441428 300__ $$a1 online resource (viii, 447 pages) :$$billustrations (some color).
001441428 336__ $$atext$$btxt$$2rdacontent
001441428 337__ $$acomputer$$bc$$2rdamedia
001441428 338__ $$aonline resource$$bcr$$2rdacarrier
001441428 347__ $$atext file$$bPDF$$2rda
001441428 4901_ $$aAdvances in experimental medicine and biology,$$x2214-8019 ;$$vvolume 1342
001441428 5050_ $$aImmune System in Action -- 2. Resistance to Immunotherapy: Mechanisms and Means for Overcoming -- 3. Immunotherapy for Melanoma -- 4. Immunotherapy in Lung Cancer: Are the promises of long-term benefit finally met? -- 5. Landscape of Immunotherapy in Genitourinary Malignancies -- 6. Immuno-oncology for Gynecologic Malignancies -- 7. Immunotherapy for Neuro-oncology -- 8. Immunotherapy in Gastrointestinal Malignancies -- 9. An update on immune based therapies in acute myeloid leukemia: 2021 and beyond! -- 10. CAR T-cells -- 11. Skin Reactions to Immune Checkpoint Inhibitors -- 12. Immunotherapy Mediated luminal Gastrointestinal toxicities -- 13. Hepatobiliary and Pancreatic Adverse Events -- 14. Pulmonary toxicities of immunotherapy -- 15. Immune checkpoint inhibitors (ICIs) related cardiotoxicity -- 16. Renal Toxicity -- 17. Immune-Related Oral, Otologic and Ocular Adverse Events -- 18. Neurologic Toxicities of Immunotherapy -- 19. Cancer Imaging in Immunotherapy. .
001441428 506__ $$aAccess limited to authorized users.
001441428 520__ $$aThe field of immuno-oncology continues to rapidly evolve as new insights to fight and treat cancer emerge. The fourth edition of Immunotherapy provides the most current overview of immuno-oncology in different cancer types and toxicities associated with immunotherapy. While immunotherapy has revolutionized the treatment landscape of several solid malignancies, several challenges still exist. Only a subset of patients derive clinical benefits; some do not respond at all, and others respond initially, only for their disease to progress later. Because these drugs can activate a broad range of immune cells, patients suffer from a unique set of side effects known as immune-related adverse events. As more immunotherapeutic agents are used in the clinic, it is important to provide updates about current and ongoing developments in the field to further research efforts and inform treatment decisions. The fourth edition will have a new focus on strategies to overcome the challenges associated with immunotherapy. Chapters will discuss topics such as biomarkers of response, resistance mechanisms, role of imaging in predicting immune-related adverse events, and management of immune-related adverse events. Written by leading experts conducting cutting-edge research, readers will gain up-to-date knowledge on the current state and future of immunotherapy. .
001441428 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed January 4, 2022).
001441428 650_0 $$aImmunotherapy.
001441428 650_6 $$aImmunothérapie.
001441428 655_7 $$aLlibres electrònics.$$2thub
001441428 655_0 $$aElectronic books.
001441428 7001_ $$aNaing, Aung,$$eeditor.
001441428 7001_ $$aHajjar, Joud,$$eeditor.
001441428 77608 $$iPrint version: $$z9783030793074
001441428 77608 $$iPrint version: $$z9783030793098
001441428 830_0 $$aAdvances in experimental medicine and biology ;$$vv. 1342.$$x2214-8019
001441428 852__ $$bebk
001441428 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-79308-1$$zOnline Access$$91397441.1
001441428 909CO $$ooai:library.usi.edu:1441428$$pGLOBAL_SET
001441428 980__ $$aBIB
001441428 980__ $$aEBOOK
001441428 982__ $$aEbook
001441428 983__ $$aOnline
001441428 994__ $$a92$$bISE